Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Vertex Pharma and CRISPR Therapeutics Release Data on 22 Patients on Gene-Editing Therapy
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP) reported new data on 22 patients, following up at a minimum of 3 months post gene-editing therapy. CTX001 has...